Part 3: What Happens When PwD Don’t Bolus for a Week with Gregory P. Forlenza, MD

Part 4: Clinical Discussion & Q&A with Gregory P. Forlenza, MD and Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP

Welcome & Housekeeping Introduction DTR X

Part 1: Worldwide Burden of NAFLD: Time for Action: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium with Prof Michael Roden, MD

Part 2: Clinical Practice Guidelines for the Management of NAFLD: Understanding the Rationale for Screening 'High Risk' Patients: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium with Kenneth Cusi, MD, FACP, FACE

Part 3: Current Therapies and Novel Therapeutic Phase 3 Data: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium with Juan Pablo Frías, MD

Part 4: Case Studies in Screening, Diagnosis & Management of NAFLD and NASH: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium with Davida F. Kruger, MSN, APN-BC, BC-ADMNP

Part 5: Audience Questions & Answers: Managing NAFLD and NASH in People with T2 Diabetes: Disease Burden • Diagnosis • Current & Emerging Armamentarium with all Faculty

Part 1: Grand Rounds Mount Sinai Hospital ESSAeducation.net: Preconception Considerations for Higher Risk Individuals with Carol J. Levy, MD, CDCES

Part 2: Grand Rounds Mount Sinai Hospital ESSAeducation.net: Updates in Contraception with Emphasis on Caring for Women with Diabetes Noel K. Strong, MD